Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-13

  Shen, Yi ^a,b   Winkler, Ingrid G ^a   Barbier, Valerie ^a   Sims, Natalie A ^c   Hendy, Jean ^c   Lévesque, Jean Pierre ^a,b  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; BONE MARROW CELL; BONE REMODELING; BONE TURNOVER; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LYMPHOPOIESIS; MALE; MOUSE; MYELOPOIESIS; NONHUMAN; OSSIFICATION; OSTEOSCLEROSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL; T LYMPHOCYTE; ZYMOGRAPHY; ANIMAL; BONE; BONE DEVELOPMENT; C57BL MOUSE; CYTOLOGY; GENETICS; HUMAN; METABOLISM;

ANIMALS; BONE AND BONES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; OSTEOGENESIS; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 77958609364     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013086     Document Type: Article

References (79)

1. Nilsson SK, Johnston HM, Coverdale JA (2001) Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 97: 2293-2299.
2. Kohler A, Schmithorst V, Filippi MD, Ryan MA, Daria D, et al. (2009) Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones. Blood 114: 290-298.
3. Lo Celso C, Fleming HE, Wu JW, Zhao CX, Miake-Lye S, et al. (2009) Liveanimal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457: 92-96.
4. Xie Y, Yin T, Wiegraebe W, He XC, Miller D, et al. (2009) Detection of functional haematopoietic stem cell niche using real-time imaging. Nature 457: 97-101.
5. Nakamura Y, Arai F, Iwasaki H, Hosokawa K, Kobayashi I, et al. (2010) Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood.
6. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, et al. (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121: 1109-1121.
7. Sugiyama T, Kohara H, Noda M, Nagasawa T (2006) Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25: 977-988.
8. Trumpp A, Essers M, Wilson A (2010) Awakening dormant haematopoietic stem cells. Nat Rev Immunol 10: 201-209.
9. Wilson A, Trumpp A (2006) Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 6: 93-106.
10. Kiel MJ, Morrison SJ (2008) Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 8: 290-301.
11. Askmyr M, Sims NA, Martin TJ, Purton LE (2009) What is the true nature of the osteoblastic hematopoietic stem cell niche? Trends in endocrinology and metabolism: TEM 20: 303-309.
12. Lévesque JP, Helwani FM, Winkler IG (2010) The "osteoblastic" niche and its role in hematopoietic stem cell homing and mobilization. Leukemia in press.
13. Lévesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ (2001) Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 98: 1289-1297.
14. Lévesque JP, Hendy J, Takamatsu Y, Williams B, Winkler IG, et al. (2002) Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol 30: 440-449.
15. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, et al. (2002) G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and upregulating CXCR4. Nat Immunol 3: 687-694.
16. Lévesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ (2003) Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 111: 187-196.
17. Lévesque JP, Hendy J, Winkler IG, Takamatsu Y, Simmons PJ (2003) Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp Hematol 31: 109-117.
18. Pelus LM, Bian H, King AG, Fukuda S (2004) Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GROβ/CXCL2 and GROβT/CXCL2Δ4. Blood 103: 110-119.
19. Pruijt JF, Fibbe WE, Laterveer L, Pieters RA, Lindley IJ, et al. (1999) Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc Natl Acad Sci USA 96: 10863-10868.
20. McQuibban GA, Butler GS, Gong JH, Bendall L, Power C, et al. (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 276: 43503-43508.
21. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, et al. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625-637.
22. Kollet O, Dar A, Shivtiel S, Kalinkovich A, Lapid K, et al. (2006) Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 12: 657-664.
23. Winkler IG, Hendy J, Coughlin P, Horvath A, Lévesque JP (2005) Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization. J Exp Med 201: 1077-1088.
24. Kuiperij HB, van Pel M, de Rooij KE, Hoeben RC, Fibbe WE (2009) Serpina1 (alpha1-AT) is synthesized in the osteoblastic stem cell niche. Exp Heamtol 37: 641-647.
25. van Pel M, van Os R, Velders GA, Hagoort H, Heegaard PM, et al. (2006) Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization. Proc Natl Acad Sci USA 103: 1469-1474.
26. Gasson JC, Golde DW, Kaufman SE, Westbrook CA, Hewick RM, et al. (1985) Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 315: 768-771.
27. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K (1992) Growthpromoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298: 29-32.
28. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A (1994) Cell growthpromoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 107(Pt 9): 2373-2379.
29. Haviernik P, Diaz MT, Haviernikova E, Tse W, Stetler-Stevenson WG, et al. (2008) Hematopoiesis in mice is extremely resilient to wide variation in TIMP/ MMP balance. Blood Cells Mol Dis 41: 179-187.
30. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP (1992) A new inhibitor of metalloproteinases from chicken: ChIMP-3. A third member of the TIMP family. J Biol Chem 267: 17321-17326.
31. Yu WH, Yu S, Meng Q, Brew K, Woessner JF, Jr. (2000) TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 275: 31226-31232.
32. Lee MH, Atkinson S, Murphy G (2007) Identification of the extracellular matrix (ECM) binding motifs of tissue inhibitor of metalloproteinases (TIMP)-3 and effective transfer to TIMP-1. J Biol Chem 282: 6887-6898.
33. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, et al. (1998) TNFalpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 435: 39-44.
34. Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, et al. (2003) A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 9: 407-415.
35. Nakajima H, Ito M, Smookler DS, Shibata F, Fukuchi Y, et al. (2010) TIMP-3 recruits quiescent hematopoietic stem cells into active cell cycle and expands multipotent progenitor pool. Blood; DOI: 10.1182/blood-2010-2001-266528.
36. Apte SS, Olsen BR, Murphy G (1995) The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 270: 14313-14318.
37. Hawkes SP, Li H, Taniguchi GT (2001) Zymography and reverse zymography for detecting MMPs, and TIMPs. Methods Mol Biol 151: 399-410.
38. Kamei M, Hollyfield JG (1999) TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest Ophthalmol Vis Sci 40: 2367-2375.
39. Lundberg P, Allison SJ, Lee NJ, Baldock PA, Brouard N, et al. (2007) Greater bone formation of Y2 knockout mice is associated with Increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem 282: 19082-19091.
40. Short BJ, Brouard N, Simmons PJ (2009) Prospective isolation of mesenchymal stem cells from mouse compact bone. Methods Mol Biol 482: 259-268.
41. Winkler IG, Sims NA, Pettit AR, Barbier V, Nowlan B, et al. (2010) Bone marrow macrophages maintain hematopoietic stem cell (HSC) niches and their depletion mobilizes HSC. Blood; DOI: 10.1182/blood-2009-2011-253534.
42. Robbins PB, Yu XJ, Skelton DM, Pepper KA, Wasserman RM, et al. (1997) Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J Virol 71: 9466-9474.
43. Zeng Y, Rosborough RC, Li Y, Gupta AR, Bennett J (1998) Temporal and spatial regulation of gene expression mediated by the promoter for the human tissue inhibitor of metalloproteinases-3 (TIMP-3)-encoding gene. Dev Dyn 211: 228-237.
44. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, et al. (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841-846.
45. Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, et al. (2004) Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103: 3258-3264.
46. Raaijmakers MH, Mukherjee S, Guo S, Zhang S, Kobayashi T, et al. (2010) Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464: 852-857.
47. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, MacArthur BD, et al. (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829-834.
48. Marquez-Curtis LA, Dobrowsky A, Montano J, Turner AR, Ratajczak J, et al. (2001) Matrix metalloproteinase and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal and leukaemic long-term marrow cultures. Br J Haematol 115: 595-604.
49. Villeneuve J, Block A, Le Bousse-Kerdiles MC, Lepreux S, Nurden P, et al. (2009) Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins. Exp Hematol 37: 849-856.
50. Lowry WE, Blanpain C, Nowak JA, Guasch G, Lewis L, et al. (2005) Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells. Genes & development 19: 1596-1611.
51. Anand-Apte B, Bao L, Smith R, Iwata K, Olsen BR, et al. (1996) A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem Cell Biol 74: 853-862.
52. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74: 111-122.
53. Blavier L, Delaisse JM (1995) Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci 108(Pt 12): 3649-3659.
54. Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, et al. (2000) Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151: 879-889.
55. Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Ann Rev Cell Developmental Biol 17: 463-516.
56. Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, et al. (2004) Altered endochondral bone development in matrix metalloproteinase 13- deficient mice. Development 131: 5883-5895.
57. Inada M, Wang Y, Byrne MH, Rahman MU, Miyaura C, et al. (2004) Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci USA101: 17192-17197.
58. Geoffroy V, Marty-Morieux C, Le Goupil N, Clement-Lacroix P, Terraz C, et al. (2004) In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass. J Bone Miner Res 19: 811-822.
59. Schiltz C, Marty C, de Vernejoul MC, Geoffroy V (2008) Inhibition of osteoblastic metalloproteinases in mice prevents bone loss induced by oestrogen deficiency. J Cell Biochem 104: 1803-1817.
60. Sato T, Foged NT, Delaisse JM (1998) The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors. J Bone Miner Res 13: 59-66.
61. Bian J, Wang Y, Smith MR, Kim H, Jacobs C, et al. (1996) Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis 17: 1805-1811.
62. Anand-Apte B, Pepper MS, Voest E, Montesano R, Olsen B, et al. (1997) Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci 38: 817-823.
63. Mahller YY, Vaikunth SS, Ripberger MC, Baird WH, Saeki Y, et al. (2008) Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors. Cancer Res 68: 1170-1179.
64. Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, et al. (1999) Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 190: 293-298.
65. Mahmoodi M, Sahebjam S, Smookler D, Khokha R, Mort JS (2005) Lack of tissue inhibitor of metalloproteinases-3 results in an enhanced inflammatory response in antigen-induced arthritis. Am J Pathol 166: 1733-1740.
66. Smookler DS, Mohammed FF, Kassiri Z, Duncan GS, Mak TW, et al. (2006) Cutting edge: tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol 176: 721-725.
67. Horiuchi K, Kimura T, Miyamoto T, Miyamoto K, Akiyama H, et al. (2009) Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF. J Immunol 182: 2093-2101.
68. Althoff K, Reddy P, Voltz N, Rose-John S, Mullberg J (2000) Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. Eur J Biochem 267: 2624-2631.
69. Brou C, Logeat F, Gupta N, Bessia C, LeBail O, et al. (2000) A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell 5: 207-216.
70. Six E, Ndiaye D, Laabi Y, Brou C, Gupta-Rossi N, et al. (2003) The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gammasecretase. Proc Natl Acad Sci USA 100: 7638-7643.
71. Rovida E, Paccagnini A, Del Rosso M, Peschon J, Dello Sbarba P (2001) TNFalpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation. J Immunol 166: 1583-1589.
72. Garton KJ, Gough PJ, Philalay J, Wille PT, Blobel CP, et al. (2003) Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J Biol Chem 278: 37459-37464.
73. Cruz AC, Frank BT, Edwards ST, Dazin PF, Peschon JJ, et al. (2004) Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells. J Biol Chem 279: 5612-5620.
74. Horiuchi K, Morioka H, Takaishi H, Akiyama H, Blobel CP, et al. (2009) Ectodomain shedding of FLT3 ligand is mediated by TNF-alpha converting enzyme. J Immunol 182: 7408-7414.
75. Akashi K, Traver D, Miyamoto T, Weissman IL (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404: 193-197.
76. Semerad CL, Christopher MJ, Liu F, Short B, Simmons PJ, et al. (2005) G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 106: 3020-3027.
77. Lundberg P, Allison SJ, Lee NJ, Baldock PA, Brouard N, et al. (2007) Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem 282: 19082-19091.
78. Winkler IG, Barbier V, Wadley R, Zannettino A, Williams S, et al. (2010) Positioning of bone marrow hematopoietic and stromal cells relative to blood flow in vivo: Serially reconstituting hematopoietic stem cells reside in distinct non-perfused niches. Blood.
79. Sims NA, Brennan K, Spaliviero J, Handelsman DJ, Seibel MJ (2006) Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling. Am J Physiol Endocrinol Metab 290: E456-462.